학술논문
LBA48 Pathologic response and exploratory analyses of neoadjuvant-adjuvant versus adjuvant pembrolizumab (PEM) for resectable stage IIIb-IV melanoma from SWOG S1801
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S1288-S1288
Subject
Language
ISSN
0923-7534